Literature DB >> 29102850

Fetuin-A to adiponectin ratio is a promising prognostic biomarker in septic critically ill patients.

Maria Dalamaga1, Irene Karampela2.   

Abstract

Entities:  

Year:  2017        PMID: 29102850     DOI: 10.1016/j.jcrc.2017.10.040

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


× No keyword cloud information.
  6 in total

Review 1.  The Role of Adipose Tissue and Adipokines in Sepsis: Inflammatory and Metabolic Considerations, and the Obesity Paradox.

Authors:  Irene Karampela; Gerasimos Socrates Christodoulatos; Maria Dalamaga
Journal:  Curr Obes Rep       Date:  2019-12

2.  Circulating Chemerin and Its Kinetics May Be a Useful Diagnostic and Prognostic Biomarker in Critically Ill Patients with Sepsis: A Prospective Study.

Authors:  Irene Karampela; Gerasimos Socrates Christodoulatos; Natalia Vallianou; Dimitrios Tsilingiris; Evangelia Chrysanthopoulou; George Skyllas; Georgios Antonakos; Ioanna Marinou; Evaggelos Vogiatzakis; Apostolos Armaganidis; Maria Dalamaga
Journal:  Biomolecules       Date:  2022-02-12

3.  Comment to: Are fetuin-A levels beneficial for estimating timing of sepsis occurrence?

Authors:  Irene Karampela; Maria Dalamaga
Journal:  Saudi Med J       Date:  2019-01       Impact factor: 1.484

4.  Fetuin-a to adiponectin ratio is a sensitive indicator for evaluating metabolic syndrome in the elderly.

Authors:  Zhongwei Zhou; Mingzhong Sun; Hao Jin; Hongmei Chen; Huixiang Ju
Journal:  Lipids Health Dis       Date:  2020-04-06       Impact factor: 3.876

5.  Decreased plasma fetuin-A level as a novel bioindicator of poor prognosis in community-acquired pneumonia: A multi-center cohort study.

Authors:  Lili Zhao; Ying Shang; Qiongzhen Luo; Xinqian Ma; Wentao Ni; Yukun He; Donghong Yang; Yu Xu; Zhancheng Gao
Journal:  Front Med (Lausanne)       Date:  2022-07-29

6.  Future Perspectives in the Diagnosis and Treatment of Sepsis and Septic Shock.

Authors:  Irene Karampela; Paraskevi C Fragkou
Journal:  Medicina (Kaunas)       Date:  2022-06-24       Impact factor: 2.948

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.